Episode

How can we unlock the potential of large-scale health datasets?

Podcast
Behind the Genes
Published
Jan 27, 2025
Duration seconds
2273
Processing state
not_requested
Canonical source
https://genomicsengland.podbean.com/e/how-can-we-unlock-the-potential-of-large-health-datasets/
Audio
https://mcdn.podbean.com/mf/web/cauy256bhymv7xwi/Behind_the_Genes_09_How_can_we_unlock_the_potential_of_large_health_datasets.mp3
JSON
/v1/public/podcasts/behind-the-genes-3509739/episodes/how-can-we-unlock-the-potential-of-large-scale-health-datasets
Markdown
/podcast/behind-the-genes-3509739/how-can-we-unlock-the-potential-of-large-scale-health-datasets.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/behind-the-genes-3509739/episodes/how-can-we-unlock-the-potential-of-large-scale-health-datasets/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/behind-the-genes-3509739/how-can-we-unlock-the-potential-of-large-scale-health-datasets.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, our guests discuss the potential of large-scale health datasets to transform research and improve patient outcomes and healthcare systems. Our guests also delve into the ethical, logistical, and technical challenges that come with these programmes. We hear how organisations such as UK Biobank, Our Future Health, and All of Us are collecting rich, diverse datasets, collaborating and actively working to ensure that these resources are accessible to researchers worldwide. Hosting this episode is Dr Natalie Banner, Director of Ethics at Genomics England. She is joined by Dr Raghib Ali, Chief Medical Officer and Chief Investigator at Our Future Health, Professor Naomi Allen, Professor of Epidemiology at the Nuffield Department of Population Health, University of Oxford, and Chief Scientist for UK Biobank, and Dr Andrea Ramírez, Chief Data Officer at the All of Us Research Program in the United States. "There are areas where academia and the NHS are very strong, and areas where industry is very strong, and by working together as we saw very good examples during the pandemic with the vaccine and diagnostic tests etc, that collaboration between the NHS and academia industry leads to much more rapid and wider benefits for our patients and hopefully in the future for the population as a whole in terms of early detection and prevention of disease." You can download the transcript or read it below. Natalie: Welcome to Behind the Genes Naomi: So, we talked to each other quite regularly. We have tried to learn from each other about the efficiencies of what to do and what not to do in how to run these large-scale studies efficiently. When you are trying to recruit and engage hundreds of thousands of participants, you need to do things very cost effectively. How to se…